Differential Approaches for Vaccination from Childhood to Old Age | Citedby Results | Gerontology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Differential Approaches for Vaccination from Childhood to Old Age

Gerontology (2013) 59 (3): 230–239.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial

Aihua Yao
Siyue Jia
Xin Cheng
Hongxing Pan
Zhijian Wang
Haitao Yang
Yu Xia
Jianfang Xu
Xuefen Huai
Danjing Leng
Ming Xu
Jiarong Wang
Gan Zhao
Bin Wang
Jingxin Li

BMC Infectious Diseases (2025) 25 (1)

Vaccination Strategies and Research Gaps in Hepatitis E Virus for Special Populations

Meng Wang
Binwei Duan
Mengcheng Liu
Yuxuan Zhang
Feng Wu
Guangming Li
Yabo Ouyang

Vaccines (2025) 13 (6): 621.

Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies

Samuel C. Scharffenberger
Yu-Hsin Wan
Leah J. Homad
Gargi Kher
Austin M. Haynes
Bibhav Poudel
Irika R. Sinha
Nicholas Aldridge
Ayana Pai
Madeleine Bibby
Crystal B. Chhan
Amelia R. Davis
Zoe Moodie
Maria Belen Palacio
Amelia Escolano
M. Juliana McElrath
Jim Boonyaratanakornkit
Marie Pancera
Andrew T. McGuire

Cell Reports (2024) 43 (10): 114811.

Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults

Bart Jacobs
Isabel Leroux-Roels
Jacques Bruhwyler
Nicola Groth
Gwenn Waerlop
Yorick Janssens
Jessika Tourneur
Fien De Boever
Azhar Alhatemi
Philippe Moris
Alexandre Le Vert
Geert Leroux-Roels
Florence Nicolas

Vaccines (2024) 12 (12): 1391.

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

The Journal of Infectious Diseases (2022) 225 (11): 1923.

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines

Jerri C. Caldeira
Michael Perrine
Federica Pericle
Federica Cavallo

Viruses (2020) 12 (5): 488.

Application of prophylactic vaccines in the elderly

Biljana Bufan

Arhiv za farmaciju (2019) 69 (6): 469.

Lifelong Maintenance of Oral Tolerance and Immunity Profiles in Mice Depends on Early Exposure to Antigen

E. F. Speziali
J. S. Menezes
A. F. Santiago
N. M. Vaz
A. M. C. Faria

Scandinavian Journal of Immunology (2018) 87 (2): 73.

Global Dynamics of an SVEIR Model with Age-Dependent Vaccination, Infection, and Latency

Rodrigue Yves M’pika Massoukou
Suares Clovis Oukouomi Noutchie
Richard Guiem

Abstract and Applied Analysis (2018) 2018: 1.

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules

Angelika Wagner
Erika Garner-Spitzer
Joanna Jasinska
Herwig Kollaritsch
Karin Stiasny
Michael Kundi
Ursula Wiedermann

Scientific Reports (2018) 8 (1)

Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6 months in a nonhuman primate neonate model

Beth C. Holbrook
Ralph B. D'Agostino
S. Tyler Aycock
Matthew J. Jorgensen
Mallinath B. Hadimani
S. Bruce King
Martha A. Alexander-Miller

Vaccine (2017) 35 (45): 6137.

Global Stability Results in a SVIR Epidemic Model with Immunity Loss Rate Depending on the Vaccine-Age

Raúl Peralta
Cruz Vargas-De-León
Pedro Miramontes

Abstract and Applied Analysis (2015) 2015: 1.